| Literature DB >> 19924083 |
Mira Popovic1, Snezana Janicijevic-Hudomal, Biljana Kaurinovic, Julijana Rasic, Svetlana Trivic, Matilda Vojnović.
Abstract
The aim of this work was to investigate the effect on antioxidant potential of some commonly used drugs (morphine, tramadol, bromocriptine, haloperidol and azithromycin) on immobilization stress (IS) combined with cold restraint stress (CRS) in the rat. After the drug treatment the animals were kept immobilized in the cold chamber at 4+/-0.3 degrees C for 3 hours and then decapitaed and the livers were extracted. The following parameters were determined in the liver homogenate: content of reduced glutathione, activities of catalase, xanthine oxidase, glutathione reductase, glutathione peroxidase, peroxidase, and lipid peroxidation intensity. A battery of biochemical assays was used and the resulting data were statistically analyzed. Combined stress exhibited a prooxidative action (increased catalase activity, lowered content of reduced glutathione). Significantly enhanced catalase activity that was observed in all groups compared to the control indicates that the primary reactive oxygen species (ROS) metabolite is hydrogen peroxide, which decomposes very rapidly (very high catalase activity), thus hindering formation of OH radicals as the most toxic ROS. None of the tested drugs showed a protective effect on combined IS and CRS. The intensity of lipid peroxidation did not change either in the combined stress or under additional influence of the drugs. Probably, under our experimental conditions, the time was not sufficiently long to observe damage of lipid membrane by ROS.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19924083 PMCID: PMC6254731 DOI: 10.3390/molecules14114505
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Effects of drugs on combined IS and CRS.
| Enzyme | OO group | IO group | IM group | IT group | IB group | IH group | IA group |
|---|---|---|---|---|---|---|---|
| XOD | 8.33±0.84 | 1.91±0.19c | 2.91±0.40c,e | 3.33±0.10c,f | 2.44±0.31c,d | 2.84±0.36c,e | 2.11±0.17 c |
| CAT | 4.42±0.29 | 14.40±0.55c | 19.28±1.98c,e | 16.29±0.45c,f | 12.39±0.48c,f | 24.20±1.33c,f | 15.44±1.07c |
| Lpx | 0.65±0.09 | 0.66±0.04 | 0.70±0.04 | 0.61±0.04 | 0.68±0.02 | 0.65±0.04 | 0.72±0.06 |
| Px | 11.36±1.91 | 10.58±0.95 | 10.97±0.88 | 11.73±1.20 | 11.08±1.71 | 17.22±1.51b,f | 15.22±1.09b,f |
| GSH | 2.69±0.28 | 0.53±0.09c | 0.99±0.19c,e | 1.05±0.12c,f | 0.52±0.08c | 0.78±0.08c,e | 1.18±0.41c,d |
| GSHPx | 0.96±0.12 | 0.41±0.14c | 0.58±0.04c, d | 0.36±0.05c | 0.35±0.07c | 0.44±0.05c | 0.38±0.08c |
| GSHR | 2.93±0.20 | 4.02±0.33c | 4.19±0.49b | 3.42±0.10b,e | 4.88±0.16c,e | 5.09±0.76c,d | 4.17±0.28c |
Activities of XOD, CAT, PX, GSHPx and GSHR are expressed in nmol/mg of protein min-1; Intensity of lipid peroxidation is expressed in nmol malondialdehyde/mg protein; Content of GSH is expressed in nmol GSH/mg protein n = 5; with respect to OO group: p > 0.05 (statistically nonsignificant), a p < 0.05, b p < 0.01, c p < 0.001 with respect to IO group: p > 0.05 (statistically nonsignificant), d p < 0.05 , e p < 0.01, f p < 0.001.
ANOVA test for measured biochemical parameters.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 6.42 |
| 9.98 | ||||||||||
|
| 5.42 | 1.00 |
| 14.85 | 4.88 | ||||||||
|
| 4.99 | 1.42 | 0.43 |
| 11.87 | 1.90 | 2.98 | ||||||
|
| 5.88 | 0.54 | 0.46 | 0.89 |
| 7.97 | 2.01 | 6.89 | 3.91 | ||||
|
| 5.49 | 0.93 | 0.07 | 0.49 | 0.40 |
| 19.78 | 9.80 | 4.92 | 7.91 | 11.81 | ||
|
| 6.22 | 0.20 | 0.80 | 1.22 | 0.34 | 0.73 |
| 11.01 | 1.04 | 3.84 | 0.86 | 3.05 | 8.76 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 0.01 |
| 0.78 | ||||||||||
|
| 0.05 | 0.04 |
| 0.40 | 0.38 | ||||||||
|
| 0.04 | 0.05+ | 0.09 |
| 0.37 | 1.15 | 0.76 | ||||||
|
| 0.03 | 0.02 | 0.02 | 0.07 |
| 0.28 | 0.50 | 0.12 | 0.65 | ||||
|
| 0.00 | 0.01 | 0.05 | 0.04 | 0.03 |
| 5.86 | 6.64 | 6.26 | 5.49 | 6.14 | ||
|
| 0.08 | 0.07 | 0.03 | 0.12 | 0.04 | 0.08 |
| 3.85 | 4.64 | 4.25 | 3.49 | 4.14 | 2.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2.16 |
| 0.55 | ||||||||||
|
| 1.70 | 0.46 |
| 0.38 | 0.16 | ||||||||
|
| 1.64 | 0.52 | 0.05 |
| 0.60 | 0.05 | 0.22 | ||||||
|
| 2.17 | 0.01 | 0.47 | 0.52 |
| 0.61 | 0.06 | 0.23 | 0.01 | ||||
|
| 1.91 | 0.25 | 0.21 | 0.27 | 0.25 |
| 0.52 | 0.03 | 0.14 | 0.08 | 0.09 | ||
|
| 1.51 | 0.65 | 0.19 | 0.14 | 0.66 | 0.41 |
| 0.58 | 0.04 | 0.20 | 0.01 | 0.03 | 0.06 |
|
|
|
|
|
|
|
| |||||||
|
| 1.09 | ||||||||||||
|
| 1.25 | 0.17 | |||||||||||
|
| 0.49 | 0.60 | 0.76 | ||||||||||
|
| 1.95 | 0.86 | 0.69 | 1.46 | |||||||||
|
| 2.15 | 1.07 | 0.90 | 1.66 | 0.21 | ||||||||
|
| 1.24 | 0.15 | 0.02 | 0.75 | 0.71 | 0.92 |
Results of the ANOVA test are represented for the differences between groups for the confidence level p<0.05; + statistically significant p < 0.05; - statistically nonsignificant p > 0.05; XOD: F = 118.48, p < 0.001; D = 0.34; CAT: F= 137.01, p < 0.001; D = 0.88; LPx: F = 2.10; p > 0.05; D = 0.04; Px: F = 14.01; p < 0.001; D = 1.13; GSH: F = 47.89; p < 0.001; D = 0.18; GSHPx: F = 31.56; p < 0.001; D = 0.06; GSHR: F = 14.70; p < 0.001; D = 0.33.